<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Pharmacophore</journal-id>
      <journal-id journal-id-type="publisher-id">pharmacophorejournal.com</journal-id>
      <journal-id journal-id-type="publisher-id">Pharmacophore</journal-id>
      <journal-title-group>
        <journal-title>Pharmacophore</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2229-5402</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">pharmacophorejournal.com-6668</article-id>
      <article-id pub-id-type="doi">10.51847/J34K56LSVr</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Overview of the Pharmacological Use of Pectins and Pectin-Containing Substances: Recent Achievements and Prospects</article-title>
      </title-group>
                  <pub-date pub-type="epub">
        <day>27</day>
        <month>02</month>
        <year>2023</year>
      </pub-date>
      <volume>14</volume>
      <issue>1</issue>
      <fpage>39</fpage>
      <lpage>44</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Pharmacophore
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>This paper is an overview on the Pectins which are a group of polysaccharides from plant cells. Structural diversity makes functionality of the pectins versatile with a variety of biological, techno-functional, biomedical, and pharmaceutical properties. Nearly all the plants contain pectin, however, the majority of it is used commercially and is derived from citrus fruits, specifically oranges, lemons, grapefruit, and apples. Commercial production is judged on new features and applications in addition to economics. Recently, there has been an effort to find new sources of pectin, such as using the leftovers from the processing of pulp from sugar beet, mango, and sunflower. Pectin substances can affect the human body as follows: prebiotic effect, cholesterol reduction, anti-inflammatory and antimicrobial effect, antitumor effect, biosorbent, transportation of drugs. This article&amp;#39;s goal is to discuss pectin application techniques and pectin-containing products. The prospects of further development and use of these biopolymers are also considered.</p>
      </abstract>
      <kwd-group>
              </kwd-group>
    </article-meta>
  </front>
</article>